{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:56:00Z","timestamp":1780563360839,"version":"3.54.1"},"reference-count":22,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,11,1]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>We report about a man in his mid-50s who was prescribed pregabalin (150\u2009mg\/day) for neuropathic pain due to a herniated intervertebral disc. Four weeks later, he presented to the emergency room with symptoms consistent with delirium. After ruling out acute intoxication with a substance and neurological causes, collateral information from the family and review of his medical chart indicated potential discontinuation syndrome owing to pregabalin. Following the successful treatment and resolution of delirium, the patient revealed he had been consistently consuming pregabalin doses upwards of 2\u2009g\/day over the past 2 weeks, leading to the premature exhaustion of his prescription and an abrupt cessation. The case findings underscore the necessity for physicians to recognise the potential for pregabalin misuse and the associated withdrawal risks, including delirium.<\/jats:p>","DOI":"10.1136\/bcr-2023-258104","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T20:46:00Z","timestamp":1700253960000},"page":"e258104","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Delirium following pregabalin discontinuation in an individual with no psychiatric or substance use history"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5069-4280","authenticated-orcid":false,"given":"Harshal","family":"Awasthi","sequence":"first","affiliation":[{"name":"Addiction Psychiatry, Matra Chhaya Medical Centre, Kanpur, Uttar Pradesh, India"},{"name":"Interior Health Authority - East Kootenay, Cranbrook, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu","family":"Vohra","sequence":"additional","affiliation":[{"name":"Addiction Medicine, Matra Chhaya Medical Centre, Kanpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"2025082802150765000_16.11.e258104.1","unstructured":"US FDA . Highlights of prescribing information, . 2018 Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021446s035,022488s013lbl.pdf [Accessed 10 Aug 2023]."},{"key":"2025082802150765000_16.11.e258104.2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jamainternmed.2019.0086","article-title":"A clinical overview of off-label use of Gabapentinoid drugs","volume":"179","author":"Goodman","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2025082802150765000_16.11.e258104.3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1176\/appi.ps.202000338","article-title":"Outpatient off-label Gabapentin use for psychiatric indications among U.S. adults, 2011-2016","volume":"72","author":"Costales","year":"2021","journal-title":"Psychiatr Serv"},{"key":"2025082802150765000_16.11.e258104.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12358"},{"key":"2025082802150765000_16.11.e258104.5","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0700-x"},{"key":"2025082802150765000_16.11.e258104.6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40263-015-0303-6","article-title":"Abuse potential of Pregabalin: a systematic review","volume":"30","author":"Schjerning","year":"2016","journal-title":"CNS Drugs"},{"key":"2025082802150765000_16.11.e258104.7","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2012001200012"},{"key":"2025082802150765000_16.11.e258104.8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.wnf.0000265979.03198.33","article-title":"Acute delirium in patients with multiple sclerosis treated with Pregabalin","volume":"32","author":"Solaro","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"2025082802150765000_16.11.e258104.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1756"},{"key":"2025082802150765000_16.11.e258104.10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/2049463720912496","article-title":"Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice","volume":"14","author":"Chincholkar","year":"2020","journal-title":"Br J Pain"},{"key":"2025082802150765000_16.11.e258104.11","article-title":"Gabapentin for off-label use: evidence-based or cause for concern","volume":"12","author":"Peckham","year":"2018","journal-title":"Subst Abuse"},{"key":"2025082802150765000_16.11.e258104.12","first-page":"22","article-title":"Ask the expert: should reliance on Gabapentin\/Pregabalin be limited?","volume":"18","author":"Raouf","year":"2018","journal-title":"Pract Pain Manag"},{"key":"2025082802150765000_16.11.e258104.13","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1111\/bcp.15352","article-title":"Fatalities associated with Gabapentinoids in England (2004-2020)","volume":"88","author":"Kalk","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2025082802150765000_16.11.e258104.14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.13175\/swjpcc059-15","article-title":"Acute Pregabalin withdrawal: A case report and review of the literature Jaclyn A","volume":"10","author":"Barrett","year":"2015","journal-title":"Southwest J Pulm Crit Care"},{"key":"2025082802150765000_16.11.e258104.15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.genhosppsych.2011.11.004","article-title":"Delirium secondary to Pregabalin","volume":"34","author":"Hickey","year":"2012","journal-title":"Gen Hosp Psychiatry"},{"key":"2025082802150765000_16.11.e258104.16","first-page":"118","article-title":"Delirium after Pregabalin withdrawal","volume":"22","author":"\u00c7al\u0131\u015fkan","year":"2021","journal-title":"Alpha Psychiatry"},{"key":"2025082802150765000_16.11.e258104.17","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/rjad375","article-title":"Acute withdrawal in the postoperative setting in a patient taking standard therapeutic doses of Pregabalin","volume":"2023","author":"Kulig","year":"2023","journal-title":"J Surg Case Rep"},{"key":"2025082802150765000_16.11.e258104.18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1017\/S0317167100017418","article-title":"Delirium after Gabapentin withdrawal","volume":"40","author":"Di Fabio","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"2025082802150765000_16.11.e258104.19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/bs.acc.2022.08.001","article-title":"Drug testing in the era of new psychoactive substances","volume":"111","author":"Gerona","year":"2022","journal-title":"Adv Clin Chem"},{"key":"2025082802150765000_16.11.e258104.20","first-page":"27","article-title":"A primer on definitive gas and liquid chromatography drug testing: what Clinicians need to know","volume":"11","author":"Pesce","year":"2015","journal-title":"J Opioid Manag"},{"key":"2025082802150765000_16.11.e258104.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.08.430"},{"key":"2025082802150765000_16.11.e258104.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-258104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:15:17Z","timestamp":1756372517000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-258104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,17]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bcr-2023-258104"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-258104","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}